Proposed Data Collection Submitted for Public Comment and Recommendations, 9343-9345 [2021-02951]

Download as PDF 9343 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 395–5806. Provide written comments within 30 days of notice publication. Proposed Project Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (OMB Control No. 0920–1071, Exp. 2/28/2021)— Extension—National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). Background and Brief Description CDC/NCEZID is seeking a three-year extension of OMB control No. 0920– 1071 to continue collecting routine customer feedback on agency service delivery. Executive Order 12862 directs Federal agencies to provide service to the public that matches or exceeds the best service available in the private sector. In order to work continuously to ensure that our programs are effective and meet our customers’ needs, the National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC) (hereafter the ‘‘Agency’’) seeks to obtain OMB approval of a generic clearance to collect qualitative feedback on our service delivery. By qualitative feedback we mean information that provides useful insights on perceptions and opinions, but are not statistical surveys that yield quantitative results that can be generalized to the population of study. This collection of information is necessary to enable the Agency to garner customer and stakeholder feedback in an efficient, timely manner, in accordance with our commitment to improving service delivery. The information collected from our customers and stakeholders will help ensure that users have an effective, efficient, and satisfying experience with the Agency’s programs. This feedback will provide insights into customer or stakeholder perceptions, experiences and expectations, provide an early warning of issues with service, or focus attention on areas where communication, training or changes in operations might improve delivery of products or services. These collections will allow for ongoing, collaborative and actionable communications between the Agency and its customers and stakeholders. It will also allow feedback to contribute directly to the improvement of program management. Since getting approval in February 2018, NCEZID has utilized 0920–1071 ten separate times. The total number of responses was 15,585. The total number of burden hours was 2,525. Authorizing legislation for this collection comes from Section 301 of the Public Health Service Act (42 U.S.C. 241). The estimated annual burden hours requested for this Extension are 3,850. There is no cost to respondents other than the time to participate. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondents Form name General public ................................................. Online surveys ............................................... Focus groups ................................................. In-person surveys ........................................... Usability testing .............................................. Customer comment cards .............................. Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–02948 Filed 2–11–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–21–21CT; Docket No. CDC–2021– 0006] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of SUMMARY: VerDate Sep<11>2014 17:27 Feb 11, 2021 Jkt 253001 government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a request for emergency clearance of the information collection titled Requirement for Negative Pre-Departure Covid–19 Test Result or Documentation of Recovery from Covid–19 for all Airline or other Aircraft Passengers arriving into the United States from any foreign country. This collection accompanies a CDC Order of the same name and is designed to prohibit the introduction into the United States of any airline passenger departing from the any foreign country unless the passenger: (1) Has a negative pre-departure test result for COVID–19 (Qualifying Test), or (2) has written or electronic documentation of recovery from COVID–19 in the form of a positive viral test result and a letter from a licensed health care provider or public health PO 00000 Frm 00027 Fmt 4703 Sfmt 4703 1500 800 1000 1500 1000 Number of responses per respondent 1 1 1 1 1 Average burden per response (in hours) 30/60 2 30/60 30/60 15/60 official stating that the passenger has been cleared for travel. DATES: CDC must receive written comments on or before April 13, 2021. ADDRESSES: You may submit comments, identified by Docket No. CDC–2021– 0006 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and E:\FR\FM\12FEN1.SGM 12FEN1 9344 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices instruments, contact Jeffrey M. Zirger, of the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. SUPPLEMENTARY INFORMATION: Proposed Project Requirement for Negative PreDeparture Covid–19 Test Result or Documentation of Recovery From Covid–19 for all Airline or other Aircraft Passengers Arriving into the United States from any Foreign Country— New—National Center for Emerging Zoonotic and Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC). VerDate Sep<11>2014 17:27 Feb 11, 2021 Jkt 253001 Background and Brief Description This information collection accompanies the Notice and Order named above. Pursuant to 42 CFR 71.20 and as set forth in greater detail below, this Notice and Order prohibit the introduction into the United States of any airline passenger departing from the any foreign country unless the passenger: (1) Has a negative pre-departure test result for COVID–19 (Qualifying Test), or (2) has written or electronic documentation of recovery from COVID–19 in the form of a positive viral test result and a letter from a licensed health care provider or public health official stating that the passenger has been cleared for travel (Documentation of Recovery). The negative test must be a viral test that was conducted on a specimen collected during the three days preceding the flight’s departure from a foreign country. Passengers must retain written or electronic documentation reflecting the Qualifying Test, or Documentation of Recovery, presented to the airline and produce such documentation upon request to any U.S. government official or a cooperating state or local public health authority. Pursuant to 42 CFR 71.31(b), the Order constitutes a controlled free pratique to any airline with an aircraft arriving into the United States from any foreign country. Pursuant to the controlled free pratique, the airline must comply with the following conditions in order to receive permission for the aircraft to enter and disembark passengers in the United States: • Airline or other aircraft operator must verify that every passenger—two years of age or older—onboard the aircraft has attested to receiving a negative Qualifying Test result or to having recovered from COVID–19 after previous SARS–CoV–2 infection and being cleared to travel by a licensed health care provider or public health official. • Airline or other aircraft operator must confirm that every passenger onboard the aircraft has documentation of a negative Qualifying Test result or Documentation of Recovery from COVID–19. Certain exemptions and waivers do apply, and are as follows: • Crew members of airlines or other aircraft operators provided that they follow industry standard protocols for the prevention of COVID–19 as set forth in relevant Safety Alerts for Operators (SAFOs) issued by the Federal Aviation Administration (FAA). PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 • Airlines or other aircraft operators transporting passengers with COVID–19 pursuant to CDC authorization and in accordance with CDC guidance. • Federal law enforcement personnel on official orders who are traveling for the purpose of carrying out a law enforcement function, provided they are covered under an occupational health and safety program in accordance with CDC guidance. Those traveling for training or other business purposes remain subject to the requirements of this Order. • U.S. Department of Defense (DOD) personnel, including military personnel and civilian employees, dependents, contractors (including whole aircraft charter operators), and other U.S. government employees when traveling on DOD assets, provided that such individuals are under competent military or U.S government travel orders and observing DOD precautions to prevent the transmission of COVID–19 as set forth in Force Protection Guidance Supplement 14—Department of Defense Guidance for Personnel Traveling During the Coronavirus Disease 2019 Pandemic (December 29, 2020) including its testing guidance. • Individuals and organizations for which the issuance of a humanitarian exemption is necessary based on both (1) exigent circumstances where emergency travel is required to preserve health and safety (e.g., emergency medical evacuations) and (2) where predeparture testing cannot be accessed or completed before travel. Additional conditions may be placed on those granted such exemptions, including but not limited to, observing precautions during travel, providing consent to postarrival testing, and/or self-quarantine after arrival in the United States, as may be directed by federal, state, territorial, tribal or local public health authorities to reduce the risk of transmission or spread. CDC anticipates certain additional cost burdens to respondents and record keepers due to the requirements. These costs fall into the following categories: • Traveler testing and ancillary costs: $9,136,480,000. • Traveler deferred travel costs: $44,370,000. • Airline staff costs for digitizing attestations: $12,257,000. • Airline costs to store attestations: $1,200–$1,050,000 a year depending on size of airline and number of travelers. Estimated burden hours associated with this collection are 70,843,733. E:\FR\FM\12FEN1.SGM 12FEN1 9345 Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Form name Traveler (3rd Party Disclosure) ......... Attestation of a negative COVID–19 test/Documentation indicating clearance for travel by a licensed healthcare provider or public health official. Attestation of a negative COVID–19 test/Documentation indicating clearance for travel by a licensed healthcare provider or public health official. Request Exemption on Urgent Humanitarian Basis. Airline Desk Agent ............................ Traveler ............................................. Total ........................................... ........................................................... Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2021–02951 Filed 2–11–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–21–21CM; Docket No. CDC–2021– 0009] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Center for Health Statistics’ Research and Development Survey (RANDS) during COVID–19—Round 3. The Research and Development Survey (RANDS) is designed to quickly obtain and disseminate information about selected population health characteristics during the ongoing coronavirus pandemic, and to provide documentation supporting the validity of pandemic-related survey SUMMARY: VerDate Sep<11>2014 17:27 Feb 11, 2021 Jkt 253001 Number of responses per respondent Number of respondents Type of respondent Frm 00029 Fmt 4703 Total burden (in hours) 34,000,000 1 2 68,000,000 34,000,000 1 5/60 2,833,333 5,200 1 2 10,400 ........................ ........................ ........................ 70,843,733 questions, including questions, such as those on telehealth access and use, that will continue to be important for public health after the pandemic. DATES: Written comments must be received on or before April 13, 2021. ADDRESSES: You may submit comments, identified by Docket No. CDC–2021– 0009 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct PO 00000 Average burden per response (in hours) Sfmt 4703 or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project National Center for Health Statistics Research and Development Survey (RANDS) during COVID–19 (Round 3)— New—National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 86, Number 28 (Friday, February 12, 2021)]
[Notices]
[Pages 9343-9345]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02951]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-21-21CT; Docket No. CDC-2021-0006]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a request for 
emergency clearance of the information collection titled Requirement 
for Negative Pre-Departure Covid-19 Test Result or Documentation of 
Recovery from Covid-19 for all Airline or other Aircraft Passengers 
arriving into the United States from any foreign country. This 
collection accompanies a CDC Order of the same name and is designed to 
prohibit the introduction into the United States of any airline 
passenger departing from the any foreign country unless the passenger:
    (1) Has a negative pre-departure test result for COVID-19 
(Qualifying Test), or (2) has written or electronic documentation of 
recovery from COVID-19 in the form of a positive viral test result and 
a letter from a licensed health care provider or public health official 
stating that the passenger has been cleared for travel.

DATES: CDC must receive written comments on or before April 13, 2021.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0006 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and

[[Page 9344]]

instruments, contact Jeffrey M. Zirger, of the Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Requirement for Negative Pre-Departure Covid-19 Test Result or 
Documentation of Recovery From Covid-19 for all Airline or other 
Aircraft Passengers Arriving into the United States from any Foreign 
Country--New--National Center for Emerging Zoonotic and Infectious 
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    This information collection accompanies the Notice and Order named 
above. Pursuant to 42 CFR 71.20 and as set forth in greater detail 
below, this Notice and Order prohibit the introduction into the United 
States of any airline passenger departing from the any foreign country 
unless the passenger:
    (1) Has a negative pre-departure test result for COVID-19 
(Qualifying Test), or (2) has written or electronic documentation of 
recovery from COVID-19 in the form of a positive viral test result and 
a letter from a licensed health care provider or public health official 
stating that the passenger has been cleared for travel (Documentation 
of Recovery).
    The negative test must be a viral test that was conducted on a 
specimen collected during the three days preceding the flight's 
departure from a foreign country. Passengers must retain written or 
electronic documentation reflecting the Qualifying Test, or 
Documentation of Recovery, presented to the airline and produce such 
documentation upon request to any U.S. government official or a 
cooperating state or local public health authority.
    Pursuant to 42 CFR 71.31(b), the Order constitutes a controlled 
free pratique to any airline with an aircraft arriving into the United 
States from any foreign country. Pursuant to the controlled free 
pratique, the airline must comply with the following conditions in 
order to receive permission for the aircraft to enter and disembark 
passengers in the United States:
     Airline or other aircraft operator must verify that every 
passenger--two years of age or older--onboard the aircraft has attested 
to receiving a negative Qualifying Test result or to having recovered 
from COVID-19 after previous SARS-CoV-2 infection and being cleared to 
travel by a licensed health care provider or public health official.
     Airline or other aircraft operator must confirm that every 
passenger onboard the aircraft has documentation of a negative 
Qualifying Test result or Documentation of Recovery from COVID-19.
    Certain exemptions and waivers do apply, and are as follows:
     Crew members of airlines or other aircraft operators 
provided that they follow industry standard protocols for the 
prevention of COVID-19 as set forth in relevant Safety Alerts for 
Operators (SAFOs) issued by the Federal Aviation Administration (FAA).
     Airlines or other aircraft operators transporting 
passengers with COVID-19 pursuant to CDC authorization and in 
accordance with CDC guidance.
     Federal law enforcement personnel on official orders who 
are traveling for the purpose of carrying out a law enforcement 
function, provided they are covered under an occupational health and 
safety program in accordance with CDC guidance. Those traveling for 
training or other business purposes remain subject to the requirements 
of this Order.
     U.S. Department of Defense (DOD) personnel, including 
military personnel and civilian employees, dependents, contractors 
(including whole aircraft charter operators), and other U.S. government 
employees when traveling on DOD assets, provided that such individuals 
are under competent military or U.S government travel orders and 
observing DOD precautions to prevent the transmission of COVID-19 as 
set forth in Force Protection Guidance Supplement 14--Department of 
Defense Guidance for Personnel Traveling During the Coronavirus Disease 
2019 Pandemic (December 29, 2020) including its testing guidance.
     Individuals and organizations for which the issuance of a 
humanitarian exemption is necessary based on both (1) exigent 
circumstances where emergency travel is required to preserve health and 
safety (e.g., emergency medical evacuations) and (2) where pre-
departure testing cannot be accessed or completed before travel. 
Additional conditions may be placed on those granted such exemptions, 
including but not limited to, observing precautions during travel, 
providing consent to post-arrival testing, and/or self-quarantine after 
arrival in the United States, as may be directed by federal, state, 
territorial, tribal or local public health authorities to reduce the 
risk of transmission or spread.
    CDC anticipates certain additional cost burdens to respondents and 
record keepers due to the requirements. These costs fall into the 
following categories:
     Traveler testing and ancillary costs: $9,136,480,000.
     Traveler deferred travel costs: $44,370,000.
     Airline staff costs for digitizing attestations: 
$12,257,000.
     Airline costs to store attestations: $1,200-$1,050,000 a 
year depending on size of airline and number of travelers.
    Estimated burden hours associated with this collection are 
70,843,733.

[[Page 9345]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Traveler (3rd Party             Attestation of a      34,000,000               1               2      68,000,000
 Disclosure).                    negative COVID-
                                 19 test/
                                 Documentation
                                 indicating
                                 clearance for
                                 travel by a
                                 licensed
                                 healthcare
                                 provider or
                                 public health
                                 official.
Airline Desk Agent............  Attestation of a      34,000,000               1            5/60       2,833,333
                                 negative COVID-
                                 19 test/
                                 Documentation
                                 indicating
                                 clearance for
                                 travel by a
                                 licensed
                                 healthcare
                                 provider or
                                 public health
                                 official.
Traveler......................  Request                    5,200               1               2          10,400
                                 Exemption on
                                 Urgent
                                 Humanitarian
                                 Basis.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............      70,843,733
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-02951 Filed 2-11-21; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.